Join
Live feed
·
INSIDERFilingvia Quantisnow
CytomX Therapeutics Inc. logo

Chief Financial Officer Ogden Christopher sold $4,953 worth of shares (1,624 units at $3.05), decreasing direct ownership by 0.55% to 295,324 units (SEC Form 4) to satisfy withholding obligation

ByQuantisnow·Wall Street's wire, on your screen.
CTMX· CytomX Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CTMX (CytomX Therapeutics Inc.) and more on Quantisnow.

Chief Financial Officer Ogden Christopher sold $4,953 worth of shares (1,624 units at $3.05), decreasing direct ownership by 0.55% to 295,324 units (SEC Form 4) to satisfy withholding obligation | Quantisnow